Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| MV-198 | MV-198wk12 | U.K. | 1995 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | ABC | 12 |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| L74V, M184V | D123E, A158T, E169EK, D177E, I178L, I202X, R211RK, F214FL, D218X | K154KN, R199RI |
| >MV-198wk12| codons 30-219 KIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKVVDFRELNKRTQDFWE VQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDKEFRKYTAFTIPSINNETPGIRYQYNVL PQGWKGSPTIFQSSMTKILKPFRKQNPELVIYQYVDDLYVGSDLEIGQHITKXEELRQHL LKWGLTTPXK |
References
| Author | Title | Citation |
| Miller, V | HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy. | AIDS, 2000 |
| Rhee, SY | Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing. | AAC, 2004 |
| Rhee, SY | HIV-1 protease and reverse transcriptase mutations: Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. | J Infect Dis, 2005 |